<DOC>
	<DOCNO>NCT02882750</DOCNO>
	<brief_summary>This study monitor effect patient report outcome ( PROMs ) VATS resection SABR NSCLC deliver Leeds Cancer Centre The investigator support information Shared Decision Making ( SDM ) process . 300 consecutive patient follow prior treatment 12 month afterwards , administer multiple questionnaire ( EORTC QLQ C-30 LC-13 , PSQ-18 , Decision Self-Efficacy Scale ) remote web-based system . Deliverable : 1 . Differences VATS resection SABR term physical psychological symptom , quality life satisfaction 2 . Patient perspective Shared Decision Making Process .</brief_summary>
	<brief_title>Effect Patient Reported Outcomes VATS SABR ( LILAC )</brief_title>
	<detailed_description>1 . Methods Aim Objectives This study aim describe trajectory lung cancer patient HRQoL , symptoms function follow VATS SABR treatment Stage I-II NSCLC determine feasibility patient acceptability online self-reporting PROMs . Specific objectives study include : - To compare change treatment patient report outcome ( HRQOL Patient Satisfaction ) VATS lung resection SABR early stage lung cancer patient . - To correlate clinical outcome ( complication AEs ) Quality Life order find objective predictor major decline patient report outcome . - To identify specific factor , influence personal choice treatment ( Decision Self-Efficacy Scale ) - Establish recruitment attrition rate adherence PROMs reporting study - To describe patient choice electronic v paper questionnaires - To explore implementation issue patient staff interview . 2 . Design This observational prospective longitudinal study repeat measure ( PROMs ) , employ convenience sample consecutive patient plan VATS resection SABR stag I-II NSCLC . Outcomes measure collect prior treatment 1,3,6,12 month afterwards , administer questionnaire remote web-based system . Paper administration offer patient without Internet access . Sample size consideration Last year 100 pre-surgical quality life questionnaire collect 5 month outpatient ' clinic Leeds Cancer Centre ( LCC ) . For longitudinal study involve regular PROMs , investigator typically see 70 % consent rate 30-35 % attrition 3 months24 . Therefore investigator expectation able recruit 200 VATS 50 SABR patient recruit 12 month 12 month follow-up . In order detect minimum difference 10 % baseline value standard deviation EORTC QLQ-C30 Global Health Scale scale ( measured historical cohort 115 anatomic lung resection ) , alfa level 0.05 statistical power 90 % , sample size 115 patient surgical arm estimate .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Age 18 year . Diagnosis NSCLC either histology MDT/Tumour Board agreement &gt; 95 % likelihood diagnosis base radiological evidence . Decision either surgery SABR Able give inform consent . Able understand language questionnaire . There limit performance status . Advanced disease ( IIIIV stage ) . Patient include HRQoL study , may increase patient burden bias answer questionnaire .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Lung Cancer</keyword>
	<keyword>Quality Life</keyword>
	<keyword>VATS</keyword>
	<keyword>SABR</keyword>
</DOC>